Finance

Lists
ARE:NYSE
Alexandria Real Estate Equities, Inc
43,82 USD
-0,68%
(-0,30) 1D
43,65 USD
-0,39% (-0,17)
After hours
Closed: 13-окт., 16:00:09 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARE...
Open
44,73 USD
High
45,20 USD
Low
43,51 USD
Mkt. cap
7,64 млд
Avg. vol.
1,93 млн
Volume
0,00
Dividend
6,57%
Quarterly dividend
0,72 USD
Ex-dividend date
2026-ж., 30-сен.
52-wk high
78,54 USD
52-wk low
39,41 USD
EPS
-6,06 USD
Beta
1,16
Shares outstanding
174,25 млн
No. of employees
514
Open
44,73 USD
High
45,20 USD
Low
43,51 USD
Mkt. cap
7,64 млд
Avg. vol.
1,93 млн
Volume
0,00
Dividend
6,57%
Quarterly dividend
0,72 USD
Ex-dividend date
2026-ж., 30-сен.
52-wk high
78,54 USD
52-wk low
39,41 USD
EPS
-6,06 USD
Beta
1,16
Shares outstanding
174,25 млн
No. of employees
514
News stories
From web sources and news partners
Profile
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area. The company is dependent on the life sciences industry and funding for research by the United States Government. The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms. The company is named after Alexandria, Egypt because of that city's connection to science. Wikipedia
About Alexandria Real Estate Equities, Inc
CEOPeter M. Moglia
Employees514
Founded1994-ж., 1-янв.
HeadquartersПасадена, Калифорния, Америка Кошмо Штаттары
SectorReal estate investment trust
Websiteare.com
Analyst ratings
Based on 11 analysts giving stock ratings to ARE in the past 3 months
Hold
Buy
2
Hold
7
Sell
2
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ARE in the last 3 months.
Highest
Current 43,82 USD
59,00 USD (+34,64%)
Average
52,30 USD (+19,35%)
Lowest
41,00 USD (-6,44%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Kim
BMO Capital
Hold
Downgraded
41,00 USD
-6,4%
10/12/2026
Anthony Paolone
J.P. Morgan
Sell
Downgraded
56,00 USD
+27,8%
09/24/2026
James Kammert
Evercore ISI
Buy
Maintained
59,00 USD
+34,6%
09/21/2026
Julien Blouin
Goldman Sachs
Hold
Maintained
54,00 USD
+23,2%
08/25/2026
Farrell Granath
Bank of America Securities
Hold
Maintained
55,00 USD
+25,5%
08/24/2026
Wes Golladay
Robert W. Baird
Hold
Maintained
52,00 USD
+18,7%
08/24/2026
Michael Carroll
RBC Capital
Hold
Maintained
51,00 USD
+16,4%
08/10/2026
Nicholas Joseph
Citi
Hold
Maintained
50,00 USD
+14,1%
08/10/2026
Richard Anderson
Cantor Fitzgerald
Hold
Reiterated
52,00 USD
+18,7%
08/04/2026
Ronald Kamdem
Morgan Stanley
Sell
Maintained
53,00 USD
+20,9%
08/04/2026
Michael Tupholme
TD Cowen
Buy
Reiterated
-
-
07/30/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
60,00 USD
+36,9%
07/06/2026
Jeffrey Spector
Bank of America Securities
Hold
Maintained
54,00 USD
+23,2%
06/26/2026
Jonathan Petersen
Jefferies
Hold
Maintained
57,00 USD
+30,1%
01/30/2026
Next call 13 күндөн кийин
27-окт., шейш., 20:00
Fiscal period
Q3 2026
- /
Revenue / Est. (USD)
- / 649,84 млн
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
752,14 млн
754,11 млн
670,88 млн
663,20 млн
Cost of goods sold
239,23 млн
232,54 млн
224,14 млн
207,34 млн
Cost of revenue
239,23 млн
232,54 млн
224,14 млн
207,34 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,22 млн
28,02 млн
34,68 млн
36,86 млн
Operating expense
369,45 млн
350,08 млн
340,13 млн
341,24 млн
Total operating expenses
608,69 млн
582,63 млн
564,27 млн
548,58 млн
Operating income
143,46 млн
171,48 млн
106,61 млн
114,62 млн
Other non operating income
-
-
-
-
EBT including unusual items
-197,84 млн
-995,35 млн
398,38 млн
-38,97 млн
EBT excluding unusual items
116,77 млн
105,81 млн
37,44 млн
183,50 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-232,75 млн
-1,08 млд
361,65 млн
-72,78 млн
Net profit margin
-30,95%
-143,33%
53,91%
-10,97%
Earnings per share
0,50
-
-
0,15
Interest and investment income
28,16 млн
-
-
133,23 млн
Interest expense
-54,85 млн
-65,67 млн
-69,17 млн
-64,34 млн
Net interest expenses
-26,69 млн
-65,67 млн
-69,17 млн
68,88 млн
Depreciation and amortization charges
340,23 млн
322,06 млн
305,44 млн
304,38 млн
EBITDA
477,23 млн
487,66 млн
406,43 млн
410,62 млн
Gain or loss from assets sale
-9,37 млн
-619,91 млн
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору